These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15979531)

  • 1. Knowledge of hepatitis among active drug injectors at a syringe exchange program.
    Carey J; Perlman DC; Friedmann P; Kaplan WM; Nugent A; Deutscher M; Masson CL; Des Jarlais DC
    J Subst Abuse Treat; 2005 Jul; 29(1):47-53. PubMed ID: 15979531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to hepatitis B virus vaccination at syringe exchange sites.
    Altice FL; Bruce RD; Walton MR; Buitrago MI
    J Urban Health; 2005 Mar; 82(1):151-61. PubMed ID: 15746385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low knowledge and perceived Hepatitis C risk despite high risk behaviour among injection drug users in Kathmandu, Nepal.
    Loewinger G; Sharma B; Karki DK; Khatiwoda P; Kainee S; Poudel KC
    Int J Drug Policy; 2016 Jul; 33():75-82. PubMed ID: 27318773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities.
    Bowman S; Grau LE; Singer M; Scott G; Heimer R
    BMC Public Health; 2014 Aug; 14():820. PubMed ID: 25107530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users.
    Campbell JV; Garfein RS; Thiede H; Hagan H; Ouellet LJ; Golub ET; Hudson SM; Ompad DC; Weinbaum C;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S64-72. PubMed ID: 17276018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the number of injecting drug users attending an outreach syringe-exchange program and infection with human immunodeficiency virus (HIV) and hepatitis C virus: the AjUDE-Brasil project.
    Caiaffa WT; Mingoti SA; Proietti FA; Carneiro-Proietti AB; Silva RC; Lopes AC; Doneda D
    J Urban Health; 2003 Mar; 80(1):106-14. PubMed ID: 12612100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringe exchange programs --- United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(45):1488-91. PubMed ID: 21085091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis vaccination of adults].
    Jost R
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1104-9. PubMed ID: 9691345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis and HIV prevention program reached every third addict. Evaluation of a cooperative project in the county of Uppsala].
    Hedlund J; Sylvan S; Lundell E; Bondesson K; Augustini S; Bodin K; Olsson K; Carlsson AE; Lhådö M; Nytell B
    Lakartidningen; 2009 Apr 1-7; 106(14):1008-11. PubMed ID: 19485034
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis vaccination among drug users.
    Quaglio G; Lugoboni F; Mezzelani P; Des Jarlais DC; Lechi A
    Vaccine; 2006 Apr; 24(15):2702-9. PubMed ID: 16436307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Difficult to motivate intravenous addicts for vaccination against hepatitis. The campaign in Blekinge was not successful: it reached only 10 percent of the group].
    Eitrem R
    Lakartidningen; 2003 Feb; 100(6):424-6. PubMed ID: 12607435
    [No Abstract]   [Full Text] [Related]  

  • 15. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twinrix vaccination schedules among injecting drug users.
    Brim N; Zaller N; Taylor LE; Feller E
    Expert Opin Biol Ther; 2007 Mar; 7(3):379-89. PubMed ID: 17309329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.
    Bialek SR; Bower WA; Mottram K; Purchase D; Nakano T; Nainan O; Williams IT; Bell BP
    J Urban Health; 2005 Sep; 82(3):468-78. PubMed ID: 16049202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower syringe sharing and re-use after syringe legalization in Rhode Island.
    Rich JD; Hogan JW; Wolf F; DeLong A; Zaller ND; Mehrotra M; Reinert S
    Drug Alcohol Depend; 2007 Jul; 89(2-3):292-7. PubMed ID: 17386980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-travel advice, attitudes and hepatitis A and B vaccination rates among travellers from seven countries†.
    Heywood AE; Nothdurft H; Tessier D; Moodley M; Rombo L; Marano C; De Moerlooze L
    J Travel Med; 2016 Jul; 24(1):. PubMed ID: 27738112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of delivering hepatitis B vaccine to injection drug users.
    Hu Y; Grau LE; Scott G; Seal KH; Marshall PA; Singer M; Heimer R
    Am J Prev Med; 2008 Jul; 35(1):25-32. PubMed ID: 18541174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.